Gmail on Android may finally let you create, edit, and delete labels directly in the app, closing a long-standing gap with ...
The FDA approved a pill version of the GLP-1 receptor agonist semaglutide (Wegovy), making it the first oral GLP-1 agent indicated for weight loss, Novo Nordisk announced on Monday. The once-daily 25 ...
The FDA expanded the approval of flibanserin (Addyi), a drug that treats low sexual desire in women, to now include some postmenopausal women, drugmaker Sprout Pharmaceuticals announced on Monday.
An inherent principle of publication is that others should be able to replicate and build upon the authors' published claims. A condition of publication in a Nature Portfolio journal is that authors ...
I no longer work (currently) with ZPL printers. At this time, this project has no real benefit to me. The code base is a bit old now. However, I will consider adding features if there is enough ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results